| Code | 4897E | ||||||||||
| MA number | 61/0191/22-S | ||||||||||
| Product Form: | tbl flm 84x2 mg (blis.Al/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 61 - LAXANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.07.2022 |
| Validity: | 29.07.2027 |
| PIL: |
PIL_STERCORE 1 mg, 2 mg tbl flm_07 2022.pdf
|
| SPC: |
SPC_STERCORE filmom obalene tablety_05_2023.pdf
|
| Safety feature | Unknown |
| Data update: | 27.10.2023 |
